Cargando…
Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care
Autores principales: | Dipasquale, Angelo, Persico, Pasquale, Lorenzi, Elena, Bertossi, Monica, Santoro, Armando, Simonelli, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256652/ https://www.ncbi.nlm.nih.gov/pubmed/32574280 http://dx.doi.org/10.3389/fonc.2020.00926 |
Ejemplares similares
-
COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report
por: Dipasquale, Angelo, et al.
Publicado: (2021) -
Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives
por: Persico, Pasquale, et al.
Publicado: (2021) -
Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations
por: Persico, Pasquale, et al.
Publicado: (2022) -
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes
por: Simonelli, Matteo, et al.
Publicado: (2021) -
Editorial: Novel diagnostic and therapeutic strategies in the management of cerebral gliomas, Volume II
por: Bosio, Alberto, et al.
Publicado: (2023)